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40 The Journal of Thoracic and Cardiobjective: The primary graft dysfunction definition has been applied to both
ilateral lung transplantation and single lung transplantation. However, the differ-
nces between bilateral and single lung transplantation in terms of primary graft
ysfunction remain unknown. This study aims to investigate the features and utility
f the new primary graft dysfunction grading system by comparing early outcomes
rom bilateral and single lung transplantation.
ethods: The primary graft dysfunction grade of 228 consecutive lung transplants
149 bilateral and 79 single lung transplants) at multiple postoperative time points
as analyzed. Subgroup analysis with chronic obstructive pulmonary disease was
erformed to further validate the difference between bilateral lung transplantation
nd single lung transplantation.
esults: The percentage of grade 3 primary graft dysfunction in bilateral and single
ung transplants was 32% and 37% at 0 hours (T0), 9% and 33% at 12 hours (T12),
% and 26% at 24 hours (T24), and 9% and 18% at 72 hours (T72), respectively.
he prevalence of the grade 3 primary graft dysfunction (T24) was significantly
ifferent between those undergoing bilateral lung transplantation and those under-
oing single lung transplantation (P  .02). The primary graft dysfunction grade
T0) significantly correlated with the duration of intubation in both bilateral (r 
.35, P  .0001) and single (r  0.42, P  .001) lung transplantation and length of
ntensive care unit stay in both bilateral (r  0.31, P  .0002) and single (r  0.33,
 .006) lung transplantation. These differences were validated by the subgroup
nalysis.
onclusions: The prevalence of primary graft dysfunction grade is different between
ilateral and single lung transplantation and varies with time. Although the primary
raft dysfunction grade correlated with the early posttransplantation outcomes, for
he purposes of description and further studies, primary graft dysfunction in bilateral
nd single lung transplantation should be considered separately.
rimary graft dysfunction (PGD), a severe form of acute lung injury develop-
ing in the immediate postoperative period, is responsible for significant
morbidity and mortality after lung transplantation.1-6 It is apparent that 
tandardized definition and a grading system will ultimately help in the diagnosis,
reatment, and prevention of PGD.7 The International Society for Heart and Lu
ransplantation (ISHLT) Working Group on Primary Graft Dysfunction has re-
ently reported a standardized consensus defining criteria of PGD, which is ba
he recipient PaO2/fraction of inspired oxygen (FIO2) value and results of ch
adiography, and this has been applied to both bilateral lung transplantations (BLTs)
nd single lung transplantations (SLTs).7-12
vascular Surgery ● July 2006
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TXSeveral studies have attempted to show the effect of
ransplant type on posttransplantation outcomes, including
GD. The results, however, are inconclusive because these
arly studies used different PGD definitions and different
utcome variables and included different recipient underly-
ng diseases.1,2,4,6,13,14 In reality, PaO2/FIO2 early after trans-
lantation is actually a changing variable,3 and the type of
ransplantation might possibly significantly influence PaO2/
IO2 and consequent PGD grading.
Therefore we hypothesize that the components of PGD
rading might differ between BLT and SLT at mul
osttransplantation time points. The aim of this study is to
nvestigate the features and utility of the new PGD grading
ystem by comparing early outcomes from BLTs and SLTs.
atients and Methods
rom January 2000 through October 2005, a total of 228 consecutive
ung transplantations performed at The Alfred Hospital, including 149
LTs and 79 SLTs, were included in this retrospective study.
tudy Group
ll patients were divided into those who received BLTs (BLT-
otal group) and those who received SLTs (SLT-total group). To
urther validate the difference between the types of transplanta-
ions, patients with chronic obstructive pulmonary disease (COPD)
ere also analyzed separately. The diagnosis of COPD here was
efined to include smoking-related emphysema (78%), 1-antit-
ypsin deficiency (10%), obliterative bronchiolitis (10%), and
ronchial asthma (2%). The patients with COPD were divided into
groups according to the type of transplantation (BLT-COPD and
LT-COPD groups).
GD Grading
etails of PGD grading severity have been described elsewh8
riefly, the classification scheme is based on 2 clinical parameters,
ncluding the chest radiograph and PaO2/FIO2 ratio. A PaO2/FIO2
atio of greater than 300 without radiographic infiltrates is consid-
red grade 0, a PaO2/FIO2 ratio of greater than 300 with radio-
raphic infiltrates is considered grade 1, a PaO2/FIO2 ratio of
etween 200 and 300 with radiographic infiltrates is considered
Abbreviations and Acronyms
BLT  bilateral lung transplantation
CI  confidence interval
COPD  chronic obstructive pulmonary disease
FIO2  fraction of inspired oxygen
ICU  intensive care unit
ILD  interstitial lung disease
ISHLT International Society for Heart and Lung
Transplantation
PEEP  positive end-expiratory pressure
PGD  primary graft dysfunction
SLT  single lung transplantationrade 2, and a PaO2/FIO2 ratio of less than 200 with radiographic w
The Journal of Thoracicnfiltrates is considered grade 3. There are other specific inclusion-
xclusion criteria. For example, any patient using a nasal cannula
or oxygen or with an FIO2 of less than 0.3 is graded as 0 or 1 on
he basis of chest radiography; absence of infiltrates on chest
adiography is sufficient for grade 0, even if the PaO2/FIO2 ratio is
ess than 300; any patient mechanically ventilated with FIO2 of
reater than 0.5 on nitric oxide beyond 48 hours after transplan-
ation is graded as grade 3; and any patient receiving extracorpo-
eal membrane oxygenation is automatically considered grade8
ransplantation Protocol
onor assessment and management, donor-recipient matching,
urgical technique, and postoperative management proceeded ac-
ording to our standard protocol, which has been described else-
here.15-17 Although lung donor selection criteria are based
tandard criteria, extended donors are commonly considered and
sed at our institution.
Preoperative immunologic evaluation was routinely performed.
he presence of preformed antibodies to human leukocyte antigen
as assessed with a panel-reactive antibody assay, and a prospec-
ive donor-recipient T-cell and B-cell cross-match was performed
n the vast majority of cases.
ung Procurement and Preservation
ung procurement and preservation followed standard proce-
ures.18,19 This includes an intravenous infusion of prostacyc
Flolan; Wellcome, Sydney, Australia) at 40 to 80 ng · kg1 ·
in1 for approximately 10 minutes before crossclamping, fol-
owed by single antegrade flush with cold modified Euro-Collins
olution (60 mL/kg). From September 2004, Perfadex (Vitrolife,
öteborg, Sweden) replaced Euro-Collins solution at our institu-
ion. Before implantation, an exploratory retrograde initial flush
as performed to detect any unexpected pulmonary emboli in the
onor lung graft.10
ransplantation Procedure
ardiopulmonary bypass was not routinely performed in our in-
titution for BLT or SLT. Cardiopulmonary bypass was considered
hen intolerance of single lung ventilation caused by hemody-
amic instability was seen.20 Before completion of implantation
etrograde, followed by antegrade, reperfusion and deairing was
erformed through an untied pulmonary arterial anastomotic su-
ure line. A specific pressure- and flow-controlled technique, in-
luding leukocyte filtration, was not used.
ostoperative Management
ostoperative management in the intensive care unit (ICU) was
erformed to ensure satisfactory end-organ perfusion while main-
aining a relatively low filling pressure (cardiac index, 2.4;
ulmonary capillary wedge pressure, 10 mm Hg; and central
enous pressure, 7 mm Hg).21 Patients with PGD received 
tandardized evaluation and therapy with increasing complexity,
epending on the degree of ventilatory and hemodynamic com-
romise. A retrospective cross-match was performed to exclude
umoral rejection. Transesophageal echocardiography was per-
ormed to exclude lung torsion, pulmonary vascular obstruction, or
oth. Therapy included pressure-controlled mechanical ventilation
ith limitation of positive end-expiratory pressure, negative fluid
and Cardiovascular Surgery ● Volume 132, Number 1 141
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1
TXalance with furosemide or continuous venovenous hemofiltration,
nhaled nitric oxide at a dose of 5 to 20 ppm, and elevation of the
pper body or lateral positioning, if appropriate. For persistent
GD beyond these approaches, extracorporeal membrane oxygen-
tion was considered.22
mmunosuppression
mmunosuppression was based on triple therapy with cyclosporine
INN: ciclosporin; trough levels of 300-450 g/L), azathioprine
1.5-2.0 mg  kg1 · d1), and prednisolone (0.15 mg · kg1 ·
1), and prophylaxis for Pneumocystis carinii and cytomegalo-
irus infection was achieved with low-dose oral trimethaprim-
ulfamethoxazole and intravenous ganciclovir and oral valganci-
lovir, respectively.16
ata Collection
ll of the data were collected from an institutional transplantation
atabase and from a review of ICU records. The PaO2/FIO2 ratio was
ollected every 6 hours in the first 72 hours after final reperfusion.
hen blood gas analysis data at a specific time point were not
vailable, data closest to the time point were substituted. The donor
aO2/FIO2 ratio was the arterial blood gas result on FIO2 of 1.0
ecorded at the time of organ procurement. The graft ischemic time of
BLT was defined as the ischemic time for the second transplanted
ung in this study. The presence or absence of radiographic infiltrates
onsistent with pulmonary edema every 24 hours after transplantation
as assessed by blinded reviewers. In the BLT group a unilateral
nfiltrate was defined as an abnormal radiograph.
ssessment of Outcome of PGD
uration of intubation, length of ICU stay, and 30-day mortality
ere used as outcome indicators of PGD.
tatistical Analysis
ontinuous data were initially assessed for normality and ex-
ressed as means  standard error. Categoric data were expressed
s counts and proportions. Comparison between groups was per-
ormed with the 2 or Fisher exact tests for categoric variables,
ith the Student t test for parametric continuous variables, or with
he Mann-Whitney U test for nonparametric continuous variables,
f appropriate. Repeated-measures variables, including PaO2/FIO2
atio, were analyzed with 2-way repeated-measures analysis of
ariance, and multiple comparisons between PGD grades were
nalyzed with factorial analysis of variance, followed by the post-
oc test. The duration of intubation and length of ICU stay were
stimated by using the Kaplan-Meier method, and the curves were
nalyzed by using the log-rank test. Correlation analysis between
GD grade and the duration of intubation and length of ICU stay
ere performed by using Pearson correlation analysis. Univariate
nalysis for 30-day mortality was conducted with logistic regres-
ion. Analysis was performed with the Statview 5.0 software
ackage (SAS Institute Inc, Cary, NC).
esults
onor and Recipient Demographics
emographics of the donors and recipients are shown in
able E1. The ages of the recipients in both the BLT-totas
42 The Journal of Thoracic and Cardiovascular Surgery ● Julynd BLT-COPD groups were significantly younger than
hose in the SLT-total and SLT-COPD groups (P  .0001
nd P  .0008, respectively). All of the patients with cystic
brosis and pulmonary hypertension underwent BLT.
ime from First and Second Lung Reperfusion to
dmission to the ICU
n the BLT-total group the times from first and second lung
eperfusion to admission to the ICU were 227  6 and 114
6 minutes, respectively. The difference between the first
nd the second lung reperfusion time was 108  6 minutes.
n the SLT-total group the time from reperfusion to admis-
ion to the ICU was 114  6 minutes, and this was similar
o that from the second lung reperfusion to admission to the
CU in the BLT-total group. Only 1 patient exceeded 6
ours from final reperfusion to admission to the ICU.
osttransplantation Oxygenation
he PaO2/FIO2 ratio in the first 72 hours after transplantation
s shown in Figure 1. The PaO2/FIO2 ratio in the BLT-total
roup was significantly greater than that in the SLT-total
roup throughout the first 72 hours (P  .0001). The PaO2/
IO2 ratio in the BLT-COPD subgroup was also significantly
reater than that in the SLT-COPD subgroup (P  .002). In
he BLT groups the PaO2/FIO2 ratio increased in the first 12
ours and thereafter remained relatively stable throughout
he first 72 hours. In contrast, the PaO2/FIO2 ratio in the SLT
roups decreased in the first 6 hours, increased gradually,
nd then decreased again after 24 hours. The pattern of the
urves between the total and COPD groups seemed to be
imilar. A similar pattern of the curves was also seen in
atients with interstitial lung disease (ILD).
revalence of PaO2/FIO2 ratio stratified by PGD
riteria
n the BLT-total group the percentage of patients with a
aO2/FIO2 ratio of less than 200 decreased in the first 12
ours, from 40% at 0 hours to 10% at 12 hours, and
emained relatively stable in the subsequent period. In the
LT-total group the percentage of patients with a PaO2/FIO2
atio of less than 200 decreased gradually, from 43% at 0
ours to 24% at 72 hours. There was a significant difference
n the prevalence of patients with a PaO2/FIO2 ratio of less
han 200 at 24 hours (P .04). Similar trends of prevalence
f various PaO2/FIO2 ratios versus time were seen in the
OPD subgroups (P  .03, Figure 2).
hest Radiography
he relative proportion of patients having an infiltrate on
hest radiography at 0, 24, 48, and 72 hours was 58%, 69%,
7%, and 66% in the BLT-total group and 65%, 79%, 77%,
nd 76% in the SLT-total group, respectively. In the COPD
lubgroups the proportions were 49%, 61%, 59%, and 58%
2006
i
i
P
I
d
a
p
S
h
h
h
w  the
s
v
t
t
2
d
D
T
p
r
B
l
Oto et al Cardiothoracic Transplantation
TXn the BLT-COPD subgroup and 60%, 76%, 75%, and 70%
n the SLT-COPD subgroup, respectively.
GD Grading
n the BLT-total group the percentage of grade 3 PGD
ecreased in the first 12 hours, from 32% at 0 hours to 9%
t 12 hours, and remained relatively stable in the subsequent
eriod. In contrast, the percentage of grade 3 PGD in the
LT-total group decreased gradually throughout the first 72
ours, and the actual values were 37% at 0 hours, 33% at 12
ours, 26% at 24 hours, 23% at 48 hours, and 18% at 72
ours. A similar trend of prevalence of various PGD grades
as seen in the COPD subgroups (Figure 3). Despite
Figure 1. PaO2/fraction of inspired oxygen (FIO2) ratio
transplant recipients. B, Subgroup analysis for recipie
Figure 2. Prevalence of various PaO2/fraction of inspire
pulmonary disease (COPD) stratified by primary graft d
B, Single lung transplant recipients.
The Journal of Thoracicimilarity of the percentage of patients remaining intubated
ersus time in the BLT-COPD and SLT-COPD subgroups,
he percentage of patients with PGD grade 3 was higher in
he SLT-COPD subgroup throughout the first 72 hours. At
4 hours, the prevalence of grade 3 PGD was significantly
ifferent between the 2 subgroups (P  .03).
uration of Intubation and Length of ICU Stay
wo (1.3%) patients in the BLT-total group and 16 (20%)
atients in SLT-total group were extubated in the operating
oom after transplantation. The duration of intubation in the
LT-total group (median, 19 hours) was significantly
onger than that in the SLT-total group (median, 8 hours),
he first 72 hours after transplantation. A, Total lung
ith chronic obstructive pulmonary disease (COPD).
gen (FIO2) ratios in recipients with chronic obstructive
ction criteria. A, Bilateral lung transplant recipients.in t
nts wd oxy
ysfunand Cardiovascular Surgery ● Volume 132, Number 1 143
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1
TXnd the percentage of patients remaining intubated at 24, 48,
nd 72 hours was 36%, 24%, and 20% in the BLT-total
roup and 27%, 23%, and 18% in the SLT-total group,
espectively (P  .03). The length of ICU stay in the
LT-total (median, 3 days) and SLT-total (median, 2 days)
roups was similar (P  .36). The duration of intubation
nd length of ICU stay in the COPD subgroups is shown in
igure E1. Although the duration of intubation in the B
OPD subgroup (median, 20 hours) tended to be longer
han that in the SLT-COPD subgroup (median, 8 hours),
here were no significant differences between them (P 
14). The length of ICU stay in the BLT-COPD (median, 3
ays) and SLT-COPD (median, 2 days) subgroups was
imilar (P  .49).
Figure 3. Prevalence of various primary graft dysfunc
pulmonary disease (COPD). A, Bilateral lung transplan
able 1. Correlation between primary graft dysfunction gr
ime factor
BLT-COPD group (n  43)
Coefficient 95% CI
ntubation time
PGD 0 h 0.42 0.14 to 0.65
PGD 24 h 0.42 0.13 to 0.64
PGD 48 h 0.50 0.21 to 0.70
PGD 72 h 0.45 0.17 to 0.67
ICU stay
PGD 0 h 0.49 0.21 to 0.69
PGD 24 h 0.35 0.15 to 0.59
PGD 48 h 0.59 0.34 to 0.76
PGD 72 h 0.56 0.31 to 0.74
LT, Bilateral lung transplantation; COPD, chronic obstructive pulmonary
raft dysfunction.
44 The Journal of Thoracic and Cardiovascular Surgery ● July-
orrelation Between PGD Grade and Early Outcomes
here was a significant correlation between the PGD grade
t 0 hours and the duration of intubation in the BLT-total (r
0.35 [95% confidence interval [CI], 0.19-0.48], P 
0001) and SLT-total (r  0.42 [95% CI, 0.18-0.62], P 
001) groups. There was also a significant correlation be-
ween the PGD grade at 0 hours and the length of ICU stay
n the BLT-total (r  0.31 [95% CI, 0.15-0.45], P  .0002)
nd SLT-total (r  0.33 [95% CI, 0.10-0.52], P  .006)
roups. In the COPD subgroups the correlation between
GD grade and duration of intubation and ICU stay at 0, 24,
8, and 72 hours are shown in Table 1. In the BLT-
ubgroup a significant correlation was seen at every time
oint. In the SLT-COPD subgroup a significant correlation
(PGD) grades in recipients with chronic obstructive
ipients. B, Single lung transplant recipients.
and duration of intubation/intensive care unit stay
SLT-COPD group (n  58)
alue Coefficient 95% CI P value
1 0.40 0.09 to 0.64 .05
1 0.31 0.01 to 0.58 .05
01 0.19 0.14 to 0.48 .27
1 0.39 0.06 to 0.65 .05
01 0.35 0.08 to 0.57 .05
5 0.28 0.01 to 0.51 .05
001 0.24 0.05 to 0.49 .10
001 0.38 0.09 to 0.61 .05
e; SLT, single lung transplantation; CI, confidence interval; PGD, primarytion
t recade
P v
.0
.0
.0
.0
.0
.0
.0
.0
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TXas seen at 0 and 72 hours; however, the correlations at 24
nd 48 hours tended to be weak, and most of these did not
each statistical significance. Patients with a higher PGD
rade at 0 hours had longer durations of intubation and
tay in the COPD subgroups (Figure 4).
xygenation Before and After Extubation
aO2/FIO2 ratios before and after extubation are shown in
igure E2. In both the BLT-COPD and SLT-COPD 
roups, the PaO2/FIO2 ratio significantly decreased after ex-
ubation (P  .0001); however, it recovered 12 hours after
xtubation, and there was no significant overall difference
etween the 2 subgroups (P  .19).
hirty-day Mortality
leven (4.8%) of a total of 228 patients died within 30 days
fter transplantation; 7 of 11 were in the BLT-total group,
nd 4 of 11 were in the SLT-total group. PGD grades at 0
ours for the 7 patients in the BLT-total group were as
ollows: PGD grade 0 (n  2), PGD grade 1 (n  1), and
GD grade 3 (n  4). All of the 4 deaths in the SLT-total
roup were PGD grade 3 at 0 hours. Although overall PGD
rade was significantly associated with 30-day mortality
odds ratio, 1.81 [95% CI, 1.04-3.14], P .03), the cause of
hese deaths were cyclosporin neurotoxicity (n  3), non-
pecific graft failure (n  2), Aspergillus species infection
n  2), and pulmonary embolism, liver failure, and mul-
isystem organ failure (n  1 each). Only 1 patient died
Figure 4. Duration of intubation and length of intensive
(PGD) grades at 0 hours (T0) in recipients with chron
higher grade had longer duration of intubation and ICU
lung transplantation (SLT).irectly of PGD. i
The Journal of Thoraciciscussion
standardized definition and grading system are necessary
o determine the incidence, associations, and root causes of
GD. The ISHLT Working Group on Primary Graft Dys-
unction has recently reported a standardized consensus
efining criteria of PGD on the basis of PaO2/FIO2 ratios that
hey suggested should be applied to both BLT and S8
owever, this study describes quite different PGD grading
or BLT and SLT, which is still evident when a single
isease (ie, COPD) is analyzed. Although we detect a sys-
ematic PGD grading difference between BLT and SLT, it is
f note that in reality the subsequent outcomes of ICU days
nd survival are the same across the 2 groups.
ime Issue for the First PGD Grading (T0)
ccording to the reported, standardized PGD-defining criteria,
he blood gas measurement for the first PGD grading (T0)
hould be performed within 6 hours of final lung reperfusion,
deally measurement on an FIO2 of 1.0 and a positive end-
xpiratory pressure (PEEP) of 5 cmH20 on mechanical venti-
ation.8 In this study all patients except one were admitte
he ICU within 6 hours after final reperfusion, and the time
rom final reperfusion to admission to the ICU was similar
etween the BLT-total and SLT-total groups. Therefore the
rst blood gas measurement in the ICU seemed to be ideal for
he first PGD grading (T0), as described in the ISHLT report,
ecause ventilator settings and measurements can be standard-
unit (ICU) stay stratified by primary graft dysfunction
structive pulmonary disease (COPD). Patients with a
in both bilateral lung transplantation (BLT) and singlecare
ic ob
stayzed.8 However, it should be noted that 20% of patients in the
and Cardiovascular Surgery ● Volume 132, Number 1 145
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1
TXLT-total group were already extubated at the time of admis-
ion to the ICU.
ifferences in PaO2/FIO2 Ratios Between the BLT and
LT Groups
revious literature described that inferior lung function,
ncluding lower oxygenation, is seen in SLT recipients
hen compared with BLT recipients 3 months after trans-
lantation.23 In the current study the PaO2/FIO2 ratio in the
LT group was significantly lower than that in the BLT
roup throughout the first 72 hours after transplantation
Figure 1). This lower PaO2/FIO2 ratio in the SLT group
ight be due to the effect of the contralateral native lung. In
he SLT-COPD subgroup not only was there ventilation-
erfusion mismatch in the native lung, but there was also a
ower PEEP during mechanical ventilation to avoid native
ung hyperinflation. Both of these factors might contribute
o a lower PaO2/FIO2 ratio after transplantation. However,
gainst this conclusion, a significantly lower PaO2/FIO2 ratio
n SLT recipients was also seen in patients with ILD in this
tudy (data not shown). In ILD the pattern of ventilation-
erfusion maldistribution is quite different from that seen in
OPD. Also in patients with ILD, similar PEEP settings are
pplied to both BLT and SLT. Therefore being disease
ndependent, the lower PaO2/FIO2 ratio in SLT recipients
eems to be a relatively constant variable because of
entilation-perfusion mismatch of the native lung, regard-
ess of the exact pattern of the mismatch.
Although the PaO2/FIO2 ratio was significantly lower in
he SLT recipients than in the BLT recipients, the duration
f intubation was shorter in the SLT-total group (P  .03)
nd tended to be shorter in the SLT-COPD subgroup (P 
14) than that in the BLT-total and BLT-COPD groups,
espectively. These paradoxical outcomes raised the possi-
ility of a possible artifact related to extubation. Extubation
ight have resulted in the loss of PEEP, with the PaO2/FIO2
atio significantly decreasing after extubation (P  .0001).
lthough the effect of extubation on the PaO2/FIO2 ratio
etween the 2 COPD subgroups was not significantly dif-
erent (Figure E2), the higher incidence of extubation in
LT group might result in a lower PaO2/FIO2 ratio and a
igher PGD grade compared with those seen in the BLT
roup at the same time point.
ifferences in PGD Between the BLT and SLT
roups
eported incidences of PGD have varied from 11% to 25%
ver transplant centers because each center used a different
efinition of PGD and different time points after transplan-
ation.1,6,24,25 Minimal actual clinical information regardin
he incidence of PGD as defined by the ISHLT consensus
rading system is available. From the very recent litera
rekker and associates26 reported in an abstract that tncidence of severe PGD grade 3 was 25% at 0 hours, 5.4% c
46 The Journal of Thoracic and Cardiovascular Surgery ● Julyt 24 hours, and 14% at 48 hours. However, the type of
ransplantation is not used as a defining criteria. This is
ndeed similar to the overall incidence of grade 3 PGD in
he current study (32% at 0 hours, 17% at 24 hours, 15% at
8 hours, and 12% at 72 hours).
Most previous PGD studies have not identified the type
f transplantation as a risk factor of PGD.1,2,6,25 The avail-
ble literature is confusing. Some studies have described a
igher incidence of PGD in BLT,4,13 and in contrast, an-
ther study has described a higher incidence of PGD in SLT
mong patients with COPD.14 Many factors, including
ackground, different prevalence of a PGD diagnosis, and
ardiopulmonary bypass use, have potentially confounded
he results.4,13
In the current study the higher incidence of PGD defined
y the ISHLT consensus grading system was seen in the
LT group, and this was also seen separately among the
ubgroups of patients with COPD and ILD (data not
hown), and yet early outcomes in SLT tended to be better
han that in the BLT group, especially duration of intuba-
ion. These seemingly contradictory results might be ex-
lained by the effects of the native lung and possible artifact
elated to extubation in patients undergoing SLT. PGD
rades at multiple time points in this study were well
orrelated with the early outcomes; however, the correlation
n the BLT group tended to be stronger than that in the SLT
roup at 24 and 48 hours. In SLT recipients the native lung
otentially contributed to lower PaO2/FIO2 ratios and a con-
equently higher PGD grade, regardless of the performance
f the transplanted graft. This effect might decrease the
ccuracy of the PGD grading as a predictor of the early
utcomes for SLT. Therefore we suggest that PGD grades in
LT and SLT should be considered and used separately.
In the analysis of 30-day mortality, although overall
GD grade was significantly associated with 30-day mor-
ality, we could not detect any difference between BLT and
LT because of the small number of events. A further study
ncluding a larger number of patients is necessary to inves-
igate the potential different effects of PGD on BLT and
LT 30-day mortality.
onclusion
he prevalence of PGD grade between BLT and SLT is
ifferent. The incidence of grade 3 PGD varies over time in
oth transplantation types, always tending to be more com-
on in SLT. The current definition of PGD in BLT and SLT
ppears to have clinical utility in both transplantation types
ecause the PGD grade correlated with the early posttrans-
lantation outcomes in both BLT and SLT. However, for
he purposes of description and further studies, the inci-
ence of the various PGD grades in BLT and SLT sho
onsidered separately.
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1
TXFigure E1. A, Percentage of patients remaining to be intubated. B, Percentage of patients remaining in the
intensive care unit (ICU). BLT, Bilateral lung transplantation; COPD, chronic obstructive pulmonary disease; SLT,
single lung transplantation.
ble E1. Demographics of the donor and recipient
Total lung transplantations (n  228) COPD (n  101)
BLT-total (n  149) SLT-total (n  79) P value BLT-COPD (n  43) SLT-COPD (n  58) P value
nor
ge (y) 36  1 37 2 .1 37  2 39  2 .1
ex (M/F) 86/63 56/23 .06 33/10 38/20 .1
ause of death .1 .1
CVA 71 31 19 24
Trauma 49 31 15 21
Anoxia 20 8 6 7
Others 9 9 3 6
aO2/FIO2 ratio 465 8 474 10 .1 463 13 479  12 .1
cipient
ge (y) 40 1 57 1 .0001 52 1 57  1 .001
ex (M/F) 88/61 48/31 .1 29/14 29/29 .1
iagnosis .0001
COPD 43 58 43 58
CF 76 0
ILD 17 21
PH 13 0
PB use 31 10 .1 1 2 .1
schemic time (min) 401 11 369  17 .1 383 21 368  20 .1
PD, Chronic obstructive pulmonary disease; BLT, bilateral lung transplantation, SLT, single lung transplantation; CVA, cerebrovascular accident;
2/FIO2, ratio of arterial oxygen tension to inspired oxygen consumption; CF, cystic fibrosis; ILD, interstitial lung disease; PH, pulmonary hypertension, CPB,
diopulmonary bypass.a
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TXFigure E2. PaO2/fraction of inspired oxygen (FIO2) ratio before and
after extubation in recipients with chronic obstructive pulmonary
disease (COPD). BLT, Bilateral lung transplantation; SLT, single
lung transplantation.The Journal of Thoracic and Cardiovascular Surgery ● Volume 132, Number 1 147.e2
